Tadashi Nagai

3.5k total citations · 1 hit paper
115 papers, 2.4k citations indexed

About

Tadashi Nagai is a scholar working on Hematology, Genetics and Molecular Biology. According to data from OpenAlex, Tadashi Nagai has authored 115 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 51 papers in Hematology, 36 papers in Genetics and 30 papers in Molecular Biology. Recurrent topics in Tadashi Nagai's work include Acute Myeloid Leukemia Research (19 papers), Chronic Myeloid Leukemia Treatments (18 papers) and Chronic Lymphocytic Leukemia Research (17 papers). Tadashi Nagai is often cited by papers focused on Acute Myeloid Leukemia Research (19 papers), Chronic Myeloid Leukemia Treatments (18 papers) and Chronic Lymphocytic Leukemia Research (17 papers). Tadashi Nagai collaborates with scholars based in Japan, United States and Greece. Tadashi Nagai's co-authors include Keiya Ozawa, Kazuo Muroi, Katsutoshi Ozaki, Kazuya Sato, Iekuni Oh, Akiko Meguro, Keiko Hatanaka, Norio Komatsu, Norio Hayashi and Masayuki Yamamoto and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Tadashi Nagai

114 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nitric oxide plays a critical role in suppression of T-cell proliferation by mesenchymal stem cells

2006 757 citations Kazuya Sato, Katsutoshi Ozaki et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tadashi Nagai Japan	23	976	966	716	348	327	115	2.4k
Kazuo Muroi Japan	21	819 0.8×	1.1k 1.2×	764 1.1×	502 1.4×	444 1.4×	160	2.5k
Martin Champagne Canada	25	832 0.9×	613 0.6×	855 1.2×	365 1.0×	421 1.3×	59	2.5k
Andree Zibert Germany	22	759 0.8×	1.1k 1.1×	246 0.3×	296 0.9×	489 1.5×	57	2.9k
Philippe Schafhausen Germany	22	951 1.0×	643 0.7×	583 0.8×	555 1.6×	171 0.5×	70	2.0k
Yuji Kishimoto Japan	19	1.3k 1.4×	716 0.7×	644 0.9×	274 0.8×	171 0.5×	69	2.3k
Andrew Dunbar United States	22	960 1.0×	487 0.5×	830 1.2×	267 0.8×	163 0.5×	55	2.0k
Philippe Guardiola France	26	737 0.8×	500 0.5×	1.1k 1.5×	336 1.0×	442 1.4×	61	2.3k
Nils von Neuhoff Germany	28	1.2k 1.2×	686 0.7×	1.0k 1.4×	465 1.3×	421 1.3×	99	2.9k
Masahiro Masuya Japan	26	768 0.8×	495 0.5×	722 1.0×	433 1.2×	694 2.1×	115	2.5k
Vincent Praloran France	31	1.0k 1.1×	1.2k 1.3×	1.6k 2.2×	546 1.6×	790 2.4×	127	3.3k

Countries citing papers authored by Tadashi Nagai

Since Specialization

Citations

This map shows the geographic impact of Tadashi Nagai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tadashi Nagai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tadashi Nagai more than expected).

Fields of papers citing papers by Tadashi Nagai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tadashi Nagai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tadashi Nagai. The network helps show where Tadashi Nagai may publish in the future.

Co-authorship network of co-authors of Tadashi Nagai

This figure shows the co-authorship network connecting the top 25 collaborators of Tadashi Nagai. A scholar is included among the top collaborators of Tadashi Nagai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tadashi Nagai. Tadashi Nagai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fukutomi, Yuma, Yoshiki Shiraishi, Tsuyoshi Oguma, et al.. (2021). Prevalence of inhaled allergen-specific IgE antibody positivity in the healthy Japanese population. Allergology International. 71(1). 117–124. 14 indexed citations

Hamada, Yuto, Yuma Fukutomi, Eiji Nakatani, et al.. (2020). Optimal Aspergillus fumigatus and Asp f 1 serum IgG cut-offs for the diagnosis of allergic bronchopulmonary aspergillosis. Allergology International. 70(1). 74–80. 7 indexed citations

Nakajima, Fumiaki, et al.. (2018). A novel HLA‐C allele, HLA‐C*07:02:01:17N, with an alternative splice site. HLA. 92(1). 56–57. 4 indexed citations

Nakamura, Junko, et al.. (2017). Males without apparent alloimmunization could have HLA antibodies that recognize target HLA specificities expressed on cells. HLA. 89(5). 285–292. 2 indexed citations

Fujiwara, Shin‐ichiro, Kazuo Muroi, Raine Tatara, et al.. (2014). Intrathecal Administration of High-Titer Cytomegalovirus Immunoglobulin for Cytomegalovirus Meningitis. SHILAP Revista de lepidopterología. 2014. 1–3. 3 indexed citations

Suzuki, T., Takahiro Yamauchi, Tadashi Nagai, et al.. (2013). Phase I Study of Clofarabine in Adult Patients with Acute Myeloid Leukemia in Japan. Japanese Journal of Clinical Oncology. 43(12). 1177–1183. 3 indexed citations

Nagai, Tadashi, Hiroyuki Kobayashi, Tomonori Tsukahara, et al.. (2013). Mechanisms of resistance to azacitidine in human leukemia cell lines. Experimental Hematology. 42(4). 294–306.e2. 37 indexed citations

Kobayashi, Yukio, Hisashi Sakamaki, Shin Fujisawa, et al.. (2011). Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia: a retrospective safety analysis. International Journal of Hematology. 93(6). 745–749. 7 indexed citations

Nakamae, Hirohisa, Hirohiko Shibayama, Mineo Kurokawa, et al.. (2011). Nilotinib as frontline therapy for patients with newly diagnosed Ph+ chronic myeloid leukemia in chronic phase: results from the Japanese subgroup of ENESTnd. International Journal of Hematology. 93(5). 624–632. 15 indexed citations

10.

Nagai, Tadashi, et al.. (2010). Combination of tipifarnib and rapamycin synergistically inhibits the growth of leukemia cells and overcomes resistance to tipifarnib via alteration of cellular signaling pathways. Leukemia Research. 34(8). 1057–1063. 6 indexed citations

11.

Sato, Kazuya, Katsutoshi Ozaki, Shin‐ichiro Fujiwara, et al.. (2010). Incidental carcinomas detected by PET/CT scans in patients with malignant lymphoma. International Journal of Hematology. 92(4). 647–650. 13 indexed citations

12.

Oka, Satoko, Tomohiro Matsuyama, Masaki Mori, et al.. (2009). EVALUATION OF PLATELET TRANSFUSION THRESHOLD IN PATIENTS WITH ACUTE LEUKEMIA RECEIVING INDUCTION CHEMOTHERAPY. Japanese Journal of Transfusion and Cell Therapy. 55(5). 589–595. 4 indexed citations

13.

Oka, Satoko, Kazuo Muroi, Tomohiro Matsuyama, et al.. (2009). Correlation between flow cytometric identification of CD33-positive cells and morphological evaluation of myeloblasts in bone marrow of patients with acute myeloblastic leukemia. Hematology. 14(3). 133–138. 6 indexed citations

14.

Oka, Satoko, Kazuya Sato, Masuzu Ueda, et al.. (2007). Flow cytometric evaluation of endoscopic biopsy specimens from patients with gastrointestinal tract B-cell lymphoma: a preliminary report. 30. 173–180. 2 indexed citations

15.

Kikuchi, Satoru, et al.. (2007). Active FKHRL1 overcomes imatinib resistance in chronic myelogenous leukemia‐derived cell lines via the production of tumor necrosis factor‐related apoptosis‐inducing ligand. Cancer Science. 98(12). 1949–1958. 43 indexed citations

16.

Izumi, Tohru, Kazuya Sato, Masuzu Ueda, et al.. (2006). Clinical significance of flow cytometric evaluation of bone marrow involvement in B-cell lymphoma. 29. 105–113. 1 indexed citations

17.

Sato, Kazuya, Tadashi Nagai, Kazuo Muroi, Norio Komatsu, & Keiya Ozawa. (2004). Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura-The associateion between the activity of Helicobacter pylori and platelet recovery-:—The associateion between the activity of Helicobacter pylori and platelet recovery—. 45(12). 1252–1254. 1 indexed citations

18.

Nagai, Tadashi, Ken Ohmine, Takuji Miyoshi, et al.. (2004). Ascorbic acid restores sensitivity to imatinib via suppression of Nrf2-dependent gene expression in the imatinib-resistant cell line. Experimental Hematology. 32(4). 375–381. 79 indexed citations

19.

Ohmine, Ken, Tadashi Nagai, Takuji Miyoshi, et al.. (2003). Analysis of Gene Expression Profiles in an Imatinib‐Resistant Cell Line, KCL22/SR. Stem Cells. 21(3). 315–321. 34 indexed citations

20.

Nagai, Tadashi, Kazuhiko Igarashi, Kazumichi Furuyama, et al.. (1998). Regulation of NF-E2 Activity in Erythroleukemia Cell Differentiation. Journal of Biological Chemistry. 273(9). 5358–5365. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact